Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022

Salmonella Typhi infection in a patient in Pakistan initially responded to standard treatment but failed to respond to subsequent treatment. The first strain was susceptible to carbapenems and azithromycin; subsequent strains harbored the NDM-5 gene. Treatment with a combination of intravenous merop...

Descripción completa

Detalles Bibliográficos
Autores principales: Nizamuddin, Summiya, Khan, Ejaz Ahmed, Chattaway, Marie Anne, Godbole, Gauri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617351/
https://www.ncbi.nlm.nih.gov/pubmed/37877663
http://dx.doi.org/10.3201/eid2911.230499
_version_ 1785129591952637952
author Nizamuddin, Summiya
Khan, Ejaz Ahmed
Chattaway, Marie Anne
Godbole, Gauri
author_facet Nizamuddin, Summiya
Khan, Ejaz Ahmed
Chattaway, Marie Anne
Godbole, Gauri
author_sort Nizamuddin, Summiya
collection PubMed
description Salmonella Typhi infection in a patient in Pakistan initially responded to standard treatment but failed to respond to subsequent treatment. The first strain was susceptible to carbapenems and azithromycin; subsequent strains harbored the NDM-5 gene. Treatment with a combination of intravenous meropenem and colistin was successful. Carbapenem-resistant Salmonella Typhi emergence will hinder treatment.
format Online
Article
Text
id pubmed-10617351
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-106173512023-11-01 Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022 Nizamuddin, Summiya Khan, Ejaz Ahmed Chattaway, Marie Anne Godbole, Gauri Emerg Infect Dis Research Letter Salmonella Typhi infection in a patient in Pakistan initially responded to standard treatment but failed to respond to subsequent treatment. The first strain was susceptible to carbapenems and azithromycin; subsequent strains harbored the NDM-5 gene. Treatment with a combination of intravenous meropenem and colistin was successful. Carbapenem-resistant Salmonella Typhi emergence will hinder treatment. Centers for Disease Control and Prevention 2023-11 /pmc/articles/PMC10617351/ /pubmed/37877663 http://dx.doi.org/10.3201/eid2911.230499 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Nizamuddin, Summiya
Khan, Ejaz Ahmed
Chattaway, Marie Anne
Godbole, Gauri
Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022
title Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022
title_full Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022
title_fullStr Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022
title_full_unstemmed Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022
title_short Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022
title_sort case of carbapenem-resistant salmonella typhi infection, pakistan, 2022
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617351/
https://www.ncbi.nlm.nih.gov/pubmed/37877663
http://dx.doi.org/10.3201/eid2911.230499
work_keys_str_mv AT nizamuddinsummiya caseofcarbapenemresistantsalmonellatyphiinfectionpakistan2022
AT khanejazahmed caseofcarbapenemresistantsalmonellatyphiinfectionpakistan2022
AT chattawaymarieanne caseofcarbapenemresistantsalmonellatyphiinfectionpakistan2022
AT godbolegauri caseofcarbapenemresistantsalmonellatyphiinfectionpakistan2022

Ejemplares similares